These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Cure of short- and long-term experimental Chagas' disease using D0870. Urbina JA; Payares G; Molina J; Sanoja C; Liendo A; Lazardi K; Piras MM; Piras R; Perez N; Wincker P; Ryley JF Science; 1996 Aug; 273(5277):969-71. PubMed ID: 8688084 [TBL] [Abstract][Full Text] [Related]
5. Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs. Urbina JA; McKerrow JH Antimicrob Agents Chemother; 2015 Dec; 59(12):7923-4. PubMed ID: 26578701 [No Abstract] [Full Text] [Related]
6. Reply to "Drug Susceptibility of Genetically Engineered Trypanosoma cruzi Strains and Sterile Cure in Animal Models as a Criterion for Potential Clinical Efficacy of Anti-T. cruzi Drugs". Francisco AF; Lewis MD; Jayawardhana S; Taylor MC; Chatelain E; Kelly JM Antimicrob Agents Chemother; 2015 Dec; 59(12):7925. PubMed ID: 26578702 [No Abstract] [Full Text] [Related]
7. Research for new antichagasic drugs. Mester B; Claramunt RM; Elguero J; Atienza J; Gómez Barrio A; Escario JA Chem Pharm Bull (Tokyo); 1991 Aug; 39(8):1990-3. PubMed ID: 1797419 [TBL] [Abstract][Full Text] [Related]
8. Parasitological cure of Chagas disease: is it possible? Is it relevant? Urbina JA Mem Inst Oswaldo Cruz; 1999; 94 Suppl 1():349-55. PubMed ID: 10677754 [No Abstract] [Full Text] [Related]
9. Discovery and Optimization of 5-Amino-1,2,3-triazole-4-carboxamide Series against Trypanosoma cruzi. Brand S; Ko EJ; Viayna E; Thompson S; Spinks D; Thomas M; Sandberg L; Francisco AF; Jayawardhana S; Smith VC; Jansen C; De Rycker M; Thomas J; MacLean L; Osuna-Cabello M; Riley J; Scullion P; Stojanovski L; Simeons FRC; Epemolu O; Shishikura Y; Crouch SD; Bakshi TS; Nixon CJ; Reid IH; Hill AP; Underwood TZ; Hindley SJ; Robinson SA; Kelly JM; Fiandor JM; Wyatt PG; Marco M; Miles TJ; Read KD; Gilbert IH J Med Chem; 2017 Sep; 60(17):7284-7299. PubMed ID: 28844141 [TBL] [Abstract][Full Text] [Related]
10. In vivo activity of the bis-triazole D0870 against drug-susceptible and drug-resistant strains of the protozoan parasite Trypanosoma cruzi. Molina J; Brener Z; Romanha AJ; Urbina JA J Antimicrob Chemother; 2000 Jul; 46(1):137-40. PubMed ID: 10882704 [TBL] [Abstract][Full Text] [Related]
11. Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole. Benaim G; Sanders JM; Garcia-Marchán Y; Colina C; Lira R; Caldera AR; Payares G; Sanoja C; Burgos JM; Leon-Rossell A; Concepcion JL; Schijman AG; Levin M; Oldfield E; Urbina JA J Med Chem; 2006 Feb; 49(3):892-9. PubMed ID: 16451055 [TBL] [Abstract][Full Text] [Related]
12. Comparative efficacies of TAK-187, a long-lasting ergosterol biosynthesis inhibitor, and benznidazole in preventing cardiac damage in a murine model of Chagas' disease. Corrales M; Cardozo R; Segura MA; Urbina JA; Basombrío MA Antimicrob Agents Chemother; 2005 Apr; 49(4):1556-60. PubMed ID: 15793138 [TBL] [Abstract][Full Text] [Related]
13. [Experimental study on the therapeutic action of Ro 7-1051 on infections caused by different strains of Trypanosoma cruzi]. Andrade SG; Figueira RM Rev Inst Med Trop Sao Paulo; 1977; 19(5):335-41. PubMed ID: 416483 [No Abstract] [Full Text] [Related]
15. A new chemotype with promise against Trypanosoma cruzi. Wang X; Cal M; Kaiser M; Buckner FS; Lepesheva GI; Sanford AG; Wallick AI; Davis PH; Vennerstrom JL Bioorg Med Chem Lett; 2020 Jan; 30(1):126778. PubMed ID: 31706668 [TBL] [Abstract][Full Text] [Related]
16. Trypanosoma cruzi: biological characterization of a isolate from an endemic area and its susceptibility to conventional drugs. Grosso NL; Bua J; Perrone AE; Gonzalez MN; Bustos PL; Postan M; Fichera LE Exp Parasitol; 2010 Oct; 126(2):239-44. PubMed ID: 20493848 [TBL] [Abstract][Full Text] [Related]
17. Specific chemotherapy of Chagas disease: controversies and advances. Urbina JA; Docampo R Trends Parasitol; 2003 Nov; 19(11):495-501. PubMed ID: 14580960 [No Abstract] [Full Text] [Related]
19. Effects of juvenile hormone analogues (JHA) on the development of Trypanosoma cruzi. Fichera L; Esteva M; Wimmer Z; Rodriguez JB; Gros EG Z Naturforsch C J Biosci; 1995; 50(7-8):578-80. PubMed ID: 7546047 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro and in silico studies of 1H- and 2H-1,2,3-triazoles as antichagasic agents. Silva TB; Ji KNK; Petzold Pauli F; Galvão RMS; Faria AFM; Bello ML; Resende JALC; Campos VR; Forezi LDSM; da Silva FC; Faria RX; Ferreira VF Bioorg Chem; 2021 Nov; 116():105250. PubMed ID: 34469833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]